See also this year's filing and all EDGAR filings for this company.
PDF Report 0001566044_2025_VYNE_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001566044, VYNE Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 64,437,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 113,000 |
| 3 | remainder_Assets | 2,355,000 |
| 4 | LiabilitiesCurrent | 14,819,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,194,484 |
| 9 | ResearchAndDevelopmentExpense | 46,380,531 |
| 10 | remainder_Expenses | 2,667 |
| 11 | remainder_Revenues | 478,134 |
| 12 | remainder_NetIncome | 2,726,651 |
| 13 | remainder_ComprehensiveNetIncome | 6,084 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 66,905,000 |
| 1 | Liabilities | 14,819,000 |
| 2 | Expenses | 59,577,682 |
| 3 | Revenues | 478,134 |
| 4 | StockholdersEquity | 52,086,000 |
| 5 | NetIncome | -56,372,897 |
| 6 | ComprehensiveNetIncome | -56,369,855 |
| 7 | BaseVar | 72,256,276 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.40 |
| 9 | EconomicCapitalRatio | 2.61 |
Edgar->Model Mapping
Feature Distribution
Change over Time
